PolymarketOpen

Hantavirus vaccine in 2026?

No97%
Yes3%

Price checked at

Trade
Set your country to see where you can trade.Set your country →
Opens the venue in a new tab, through Predxy.
24h volume$500
7d volume$946.4
30d volume$8.7K
Liquidity$38.4K
Spread0%
ResolvesJan 1, 2027in 3 months

Probability history

Drag to move · pinch or ⌘/Ctrl+scroll to zoom

Shaded periods have no successful hourly price check.

Probability history0%25%50%75%100%Sep 2Sep 9Sep 16Sep 23Sep 30Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.Shaded periods have no successful hourly price check.

Based on this market’s outcome prices, expressed as probabilities.

Resolution rules

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.

Venue activity

Holders143
Held value—
Trades (24h)—
Trades—
Open interest—
Comments6

Best bid 3% · best ask 3%

Top holders

  • diablebleu33574848766046164159312361389126746625941229104553637902902710371273925289603
  • whitetofu65212199459705189540054970689860634578415205165846935633340159883171881149961
  • Darling-Top65212199459705189540054970689860634578415205165846935633340159883171881149961
  • Anjun65212199459705189540054970689860634578415205165846935633340159883171881149961
  • tomatosauce265212199459705189540054970689860634578415205165846935633340159883171881149961

A snapshot of positions, not a track record.

Recent trades

  • SELL3%$10.411 days ago
  • SELL3%$6.712 days ago
  • SELL3%$1012 days ago
  • SELL3%$612 days ago
  • SELL3%$17.412 days ago
  • SELL3%$25.112 days ago

Discussion on Predxy

Sign in to join the discussion.

Nobody has said anything here yet.

6 comments

Comments belong to the venue's event, not to this outcome. Every leg of the same event shares this thread.
  • Volku · 5 months ago

    make it "warp speed" approval 😄

  • dsb · 5 months ago

    there are Hantavirus vaccines. but none approved by FDA. bad market, wont touch this one

  • tomatosauce2 · 5 months ago

    Thats in early stages of research/testing. This market is for full FDA approval

  • truthbeautyjustice · 5 months ago

    The odds are extremely slim. Prediction markets on Polymarket currently price the chance at only ~13% as of May 8, 2026. The core barrier is the complete absence of any Phase 3 efficacy trial — a mandatory step before FDA approval. With only Phase 1 data available and no large-scale trials underway, the standard multi-year regulatory pathway makes 2026 approval essentially impossible under normal circumstances. The WHO has classified hantavirus as a potential "Disease X" pandemic pathogen, which may accelerate funding and urgency, but not fast enough for this year.

  • vsachy · 5 months ago

    There is actually a vaccine already made by Moderna. The market creator is an idiot

  • takecgcjof · 5 months ago

    I will trust science

As of Sep 30, 01:38 AM UTC